Abiralieva 250mg Tablet

Abiralieva 250mg Tablet Specification

Origin
India

Dosage Form
Tablet

Salt Composition
Abiraterone Acetate

Enzyme Types
Other

Feature
Other

Ingredients
Other

Application
Other

Physical Color/Texture
Other

Fermentation Smell
Normal Smell

Storage Instructions
Store at optimal temperature

Abiralieva 250mg Tablet Trade Information

Minimum Order Quantity
10 Pieces

Payment Terms
Cash in Advance (CID)

Supply Ability
45 Pieces Per Day

Delivery Time
4 Days

Sample Policy
Contact us for information regarding our sample policy

Main Domestic Market
All India

About Abiralieva 250mg Tablet

Abiralieva 250mg Tablet is an anti-cancer medication containing Abiraterone acetate, primarily used to treat metastatic castration-resistant prostate cancer (mCRPC). It belongs to the class of drugs called androgen biosynthesis inhibitors, which work by blocking the production of androgens (male hormones like testosterone) that fuel the growth of prostate cancer cells.

Brand Name: Abiralieva

Composition: Abiraterone acetate

Mechanism of Action:

It inhibits the CYP17A1 enzyme, which is crucial for androgen (testosterone) production in the adrenal glands, testes, and prostate tumor tissues. By blocking this enzyme, it significantly reduces androgen levels, depriving prostate cancer cells of the hormones they need to grow. This is particularly effective in treating metastatic castration-resistant prostate cancer (mCRPC).

Uses:

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Metastatic High-Risk Castration-Sensitive Prostate Cancer (mCSPC)

Side Effects:

Swelling

Hypokalemia (low potassium)

Hypertension (high blood pressure)

Elevated liver enzymes

Fatigue

Joint pain

Nausea

Vomiting